Joinn Laboratories(China)Co.,Ltd. (HKG:6127)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
12.18
-0.38 (-3.03%)
Apr 3, 2025, 4:08 PM HKT
32.97%
Market Cap 14.59B
Revenue (ttm) 2.15B
Net Income (ttm) 78.83M
Shares Out n/a
EPS (ttm) 0.11
PE Ratio 185.07
Forward PE n/a
Dividend 0.18 (1.44%)
Ex-Dividend Date Jun 28, 2024
Volume 3,309,826
Average Volume 3,348,290
Open 12.28
Previous Close 12.56
Day's Range 11.90 - 12.86
52-Week Range 6.31 - 17.60
Beta 0.66
RSI 38.86
Earnings Date Mar 29, 2025

About HKG:6127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I cli... [Read more]

Sector Healthcare
Founded 1995
Employees 2,510
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6127
Full Company Profile

Financial Performance

In 2024, HKG:6127's revenue was 2.02 billion, a decrease of -15.07% compared to the previous year's 2.38 billion. Earnings were 74.08 million, a decrease of -81.34%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.